Zai Lab (ZLAB) FCF Margin (2020 - 2026)

Zai Lab (ZLAB) reported FCF Margin of 295.68% for Q1 2026, down 23861.0% on a YoY basis from N/an in Q1 2025, and down 2906.67% sequentially from 10.54% in Q4 2025.

Zai Lab (ZLAB) FCF Margin (2020 - 2026) Analysis & Trends

Zai Lab (ZLAB) has 7 years of FCF Margin data on file, last reported at 295.68% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 23861.0% year-over-year to 295.68%; the trailing twelve-month figure through Mar 2026 stood at 34.14% (up 9377.0% YoY), and the FY2025 full-year result was 5342.64%, down 528736.0% from the prior year.
  • FCF Margin fell to 295.68% in Q1 2026, from 10.54% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 10.54% in Q4 2025 to a low of 10782.41% in Q2 2024.
  • A 5-year average of 1270.98% and a median of 110.22% in 2024 frame the typical range for FCF Margin.
  • Peak annual rise in FCF Margin reached 718530 bps in 2025, while the deepest fall reached 447391 bps in 2025.
  • Tracing ZLAB's FCF Margin over 5 years: stood at 183.28% in 2022, then surged by 97 bps to 5.68% in 2023, then plunged by 869 bps to 55.0% in 2024, then soared by 119 bps to 10.54% in 2025, then slumped by 2907 bps to 295.68% in 2026.
  • Business Quant data shows ZLAB's FCF Margin at 295.68% in Q1 2026, 10.54% in Q4 2025, and 4499.43% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 10.45%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 23.53%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Zai Lab 21.37 Bn 21.37 Bn -34.26 Mn -295.68%

Historic Data

Download Data
DateValue
Mar 31, 2026 -295.68%
Dec 31, 2025 10.54%
Sep 30, 2025 -4,499.43%
Jun 30, 2025 -3,597.11%
Mar 31, 2025 -57.07%
Dec 31, 2024 -55.00%
Sep 30, 2024 -25.52%
Jun 30, 2024 -10,782.41%
Mar 31, 2024 -104.51%
Dec 31, 2023 -5.68%
Sep 30, 2023 -82.38%
Mar 31, 2023 -115.93%
Dec 31, 2022 -183.28%
Sep 30, 2022 -231.16%
Jun 30, 2022 -100.97%
Mar 31, 2022 -210.15%
Dec 31, 2021 -362.51%
Jun 30, 2021 -189.01%
Mar 31, 2021 -851.53%
Dec 31, 2020 -328.81%